Recent research reported that HSPA4 is a tumor membrane antigen that can promote tumor metastasis by activating the NF-κB pathway in tumor cells once ligated with the pathogenic anti-HSPA4 IgG (Gu et al., 2019). This evidence concerns the gene NFKB1 and neoplasm.